Literature DB >> 8569247

Cytotoxic and anti-tumour properties of certain taxa of Umbelliferae with special reference to Centella asiatica (L.) Urban.

T D Babu1, G Kuttan, J Padikkala.   

Abstract

Centella asiatica (L.) Urban (Umbelliferae) is commonly used in the Ayurvedic system of medicine to treat various diseases. The present study examines the anti-tumour effect of the crude extract (CE) of Centella asiatica as well as its partially purified fractions (AF) from chromatographic procedures by both in vitro short and long term chemosensitivity and in vivo tumour model test systems. AF dose dependently inhibited the proliferation of the transformed cell lines significantly more than did the CE and other solvent fractions. Fifty percent effective doses on hour 3 exposure to AF were 17 and 22 micrograms/ml for Ehrlich ascites tumour cells (EAC) and Dalton's lymphoma ascites tumour cells (DLA), respectively. However, practically no toxic effects were detected in normal human lymphocytes. AF also significiantly suppressed the multiplication of mouse lung fibroblast (L-929) cells at a concentration of 8 micrograms/ml in long term culture. Oral administration of the extracts (CE and AF) retarded the development of solid and ascites tumours and increased the life span of these tumour bearing mice. Tritiated thymidine, uridine and leucine incorporation assay suggest that the fraction acts directly on DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569247     DOI: 10.1016/0378-8741(95)01284-k

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  26 in total

1.  Indigenous traditional knowledge and usage of folk bio-medicines among Rongmei tribe of Tamenglong district of Manipur, India.

Authors:  N Prakash; M A Ansari; P Punitha; P K Sharma
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-04-03

2.  Adriamycin induced myocardial failure in rats: protective role of Centella asiatica.

Authors:  A Gnanapragasam; S Yogeeta; R Subhashini; K K Ebenezar; V Sathish; T Devaki
Journal:  Mol Cell Biochem       Date:  2006-06-20       Impact factor: 3.396

3.  The inductive effects of Centella asiatica on rat spermatogenic cell apoptosis in vivo.

Authors:  Mahnaz Heidari; Hamed Heidari-Vala; Mohammad Reza Sadeghi; Mohammad Mehdi Akhondi
Journal:  J Nat Med       Date:  2011-08-26       Impact factor: 2.343

4.  Apoptosis induction of Centella asiatica on human breast cancer cells.

Authors:  Suboj Babykutty; Jose Padikkala; Priya Prasanna Sathiadevan; Vinod Vijayakurup; Thasni Karedath Abdul Azis; Priya Srinivas; Srinivas Gopala
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-10-25

Review 5.  Medicinal plants and cancer chemoprevention.

Authors:  Avni G Desai; Ghulam N Qazi; Ramesh K Ganju; Mahmoud El-Tamer; Jaswant Singh; Ajit K Saxena; Yashbir S Bedi; Subhash C Taneja; Hari K Bhat
Journal:  Curr Drug Metab       Date:  2008-09       Impact factor: 3.731

6.  Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all.

Authors:  Kashmira J Gohil; Jagruti A Patel; Anuradha K Gajjar
Journal:  Indian J Pharm Sci       Date:  2010-09       Impact factor: 0.975

7.  Antioxidant and anticancer evaluation of Scindapsus officinalis (Roxb.) Schott fruits.

Authors:  Shaktikumar C Shivhare; Arjun O Patidar; K G Malviya; K K Shivhare-Malviya
Journal:  Ayu       Date:  2011-07

8.  Antioxidant and cytotoxic activities of Centella asiatica (L) Urb.

Authors:  Frederico Pittella; Rafael C Dutra; Dalton D Junior; Miriam T P Lopes; Nádia R Barbosa
Journal:  Int J Mol Sci       Date:  2009-08-26       Impact factor: 6.208

9.  Statistical Analysis of Metal Chelating Activity of Centella asiatica and Erythroxylum cuneatum Using Response Surface Methodology.

Authors:  R J Mohd Salim; M I Adenan; A Amid; M H Jauri; A S Sued
Journal:  Biotechnol Res Int       Date:  2013-02-27

10.  Regulation of Caspase-3 and Bcl-2 Expression in Dalton's Lymphoma Ascites Cells by Abrin.

Authors:  V Ramnath; P S Rekha; G Kuttan; R Kuttan
Journal:  Evid Based Complement Alternat Med       Date:  2007-11-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.